Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Agenus Inc
(NQ:
AGEN
)
3.160
USD
-0.235 (-6.92%)
Official Closing Price
Updated: 7:50 PM EST, Mar 4, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Agenus Inc
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Agenus to Host Annual Meeting of Stockholders
June 13, 2019
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune modulating antibodies, cancer vaccines, adjuvants and adoptive cell therapies1, invites investors and the general public...
From
PR Newswire
MiMedx Announces Comprehensive Board Refreshment Plan in Cooperation with Prescience Point
May 30, 2019
Six New Directors to Join the Board
From
PR Newswire
Biotechs That Successfully Combat Cancer Could See Blockbuster Returns
May 29, 2019
NetworkNewsWire Editorial Coverage
From
PR Newswire
Agenus Inc (AGEN) Q1 2019 Earnings Call Transcript
May 10, 2019
AGEN earnings call for the period ending March 31, 2019.
Tags
AGEN
Market News
From
Motley Fool
The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stock To Debut
May 09, 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ...
Tags
SELB
RETA
CDMO
From
Benzinga
Agenus Reports First Quarter 2019 Financial Results and Provides Corporate Update
May 09, 2019
- Gilead partnership yields $150M & first milestone of $7.5M
From
PR Newswire
Agenus to Report First Quarter 2019 Financial Results on May 9, 2019 and Host Conference Call and Webcast
May 03, 2019
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune modulating antibodies, cancer vaccines, adjuvants and adoptive cell therapies1, will release its first quarter 2019...
From
PR Newswire
Benzinga's Top Upgrades, Downgrades For April 22, 2019
April 22, 2019
Top Upgrades Analysts at Raymond James upgraded Rent-A-Center Inc (NASDAQ: RCII) from Outperform to Strong Buy. Rent-A-Center ...
Tags
AGEN
Analyst Ratings
OKE
From
Benzinga
Analysts See 21% Gains Ahead For PXSG
April 12, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Biotechs Strive to Provide Patients With More Affordable Treatment Options
April 11, 2019
FinancialBuzz.com News Commentary
From
PR Newswire
Detailed Research: Economic Perspectives on Agenus, Warrior Met Coal, Cubic, Nielsen Holdings Plc, Leidos, and Limoneira — What Drives Growth in Today's Competitive Landscape
April 10, 2019
In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Agenus Inc. (NASDAQ:AGEN),...
From
GlobeNewswire News Releases
Agenus Begins Dosing with Next-Gen Anti-CTLA-4 Antibody
April 02, 2019
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune-modulating antibodies, cancer vaccines, adjuvants and adoptive cell therapies1, today announced that the first patient...
From
PR Newswire
Short Interest Makes 12.2% Move For AGEN
March 27, 2019
The most recent short interest data has been released for the 03/15/2019 settlement date, which shows a 1,080,838 share increase in total short interest for Agenus Inc (AGEN), to 9,973,177, an increase...
Tags
Stocks
From
Market News Video
IAVI Announces First-in-Human Clinical Trial of Native-like HIV Envelope Vaccine Candidate
March 27, 2019
IAVI announces Phase I trial to evaluate safety and immunogenicity of engineered envelope protein HIV vaccine candidate
From
Business Wire News Releases
Therapies Trying to Fight Against Cancer
March 25, 2019
FinancialBuzz.com News Commentary
From
PR Newswire
Agenus Announces Clinical Appointments
March 21, 2019
- Dr. Manuel Hidalgo, MD, PhD as Strategic Advisor
From
PR Newswire
3 Top Growth Stocks to Buy Right Now
March 20, 2019
Surprise! This retailer and lesser-known biotechnology company could be potential multibaggers.
Tags
FIVE
Market News
AGEN
From
Motley Fool
Agenus Inc (AGEN) Q4 2018 Earnings Conference Call Transcript
March 14, 2019
AGEN earnings call for the period ending December 31, 2018.
Tags
AGEN
Market News
From
Motley Fool
Agenus Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
March 14, 2019
- Gilead collaboration results in cash infusion of $150M; first milestone payment of $7.5M triggered
From
PR Newswire
Agenus Milestone Triggers $7.5M Payment from Gilead
March 13, 2019
- FDA has accepted IND filing for AGEN1423
From
PR Newswire
Analysts Predict 18% Gains Ahead For IEIH
March 12, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Agenus to Report Fourth Quarter and Full Year 2018 Financial Results on March 14, 2019 and Host Conference Call and Webcast
March 08, 2019
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune modulating antibodies, cancer vaccines, adjuvants and adoptive cell therapies1, will release its fourth quarter and full...
From
PR Newswire
The 3 Oldest Members of Biotech's Billion-Burned Club
March 03, 2019
These biopharmaceutical startups have been losing their investors' money for decades.
Tags
GILD
NVAX
Market News
From
Motley Fool
Analysis: Positioning to Benefit within Micron Technology, Caterpillar, Agenus, Fossil Group, Marathon Petroleum, and Geo Group — Research Highlights Growth, Revenue, and Consolidated Results
February 20, 2019
In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Micron Technology, Inc....
From
GlobeNewswire News Releases
71 Biggest Movers From Yesterday
February 19, 2019
Gainers Riot Blockchain, Inc. (NASDAQ: RIOT) shares gained 34.82 percent to close at $3.33 on Tuesday amid strength in the ...
Tags
PCG
EVH
FFHL
From
Benzinga
Agenus Launches First Asset-Backed Digital-Security Offering in Healthcare
February 19, 2019
-- Agenus Conference Call and Live Webcast Scheduled for 11:00a.m. ET today --
From
PR Newswire
Agenus to Host Call to Launch First Asset-Backed Digital-Security Offering in Healthcare on February 19, 2019
February 15, 2019
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune modulating antibodies, cancer vaccines, adjuvants and adoptive cell therapies1, announced today that its Biotech...
From
PR Newswire
Why Agenus Inc. Stock Took Flight in January
February 08, 2019
Agenus' stock crushed it last month. Here's why.
Tags
Market News
AGEN
GILD
From
Motley Fool
IEIH's Holdings Could Mean 20% Gain Potential
February 05, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Investor Movement Index January Summary
February 05, 2019
Monthly Summary The IMX decreased for the fourth month in a row in January, moving down 2.95 percent to 4.28 from a previous score of ...
Tags
GE
AGEN
T
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.